Anti-chlamydial effects of azelastine hydrochloride and the impact of the histamine H1 receptor on chlamydial development.

IF 2.4 4区 医学 Q3 MICROBIOLOGY
Jasmin Kuratli, Cory Ann Leonard, Robert Schoborg, Nicole Borel
{"title":"Anti-chlamydial effects of azelastine hydrochloride and the impact of the histamine H1 receptor on chlamydial development.","authors":"Jasmin Kuratli,&nbsp;Cory Ann Leonard,&nbsp;Robert Schoborg,&nbsp;Nicole Borel","doi":"10.1099/jmm.0.001691","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> Azelastine hydrochloride, a second-generation histamine H1 receptor (H1R) antagonist, exhibits anti-chlamydial effects against <i>Chlamydia trachomatis</i> (CT) in HeLa cells (genital infection model).<b>Hypothesis/Gap Statement.</b> Non-antibiotic pharmaceutical interactions with CT are an understudied field and the anti-chlamydial effects of azelastine are a potential interaction requiring further elucidation.<b>Aim</b>. To explore the underlying anti-chlamydial mechanisms of azelastine.<b>Methodology.</b> We assessed the specificity of azelastine for the chlamydial species and host cell type, the timing of azelastine application and whether the anti-chlamydial effects could be reproduced with different H1R-modulating compounds.<b>Results.</b> We observed similar anti-chlamydial azelastine effects for <i>Chlamydia muridarum</i> as well as for an ocular CT strain in human conjunctival epithelial cells (ocular infection model). Pre-incubating host cells with azelastine before infection mildly reduced chlamydial inclusion numbers and infectivity. Incubation of cells with azelastine initiated concomitantly with the chlamydial infection, or initiated several hours post-infection, reduced inclusion size, number and infectivity, and altered chlamydial morphology. These effects were strongest when azelastine was added shortly after or with the infection. Azelastine effects were not alleviated by increased concentrations of culture medium nutrients. Additionally, we did not observe anti-chlamydial effects when incubating cultures either with a different H1R antagonist or agonist, indicating that azelastine effects are probably H1R-independent.<b>Conclusion.</b> Accordingly, we conclude that azelastine anti-chlamydial effects are not restricted to a specific chlamydial species, strain or culture model, and are probably not mediated by H1R antagonism. Thus, it appears likely that off-target mechanisms of azelastine may explain our observations.</p>","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":"72 5","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001691","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Azelastine hydrochloride, a second-generation histamine H1 receptor (H1R) antagonist, exhibits anti-chlamydial effects against Chlamydia trachomatis (CT) in HeLa cells (genital infection model).Hypothesis/Gap Statement. Non-antibiotic pharmaceutical interactions with CT are an understudied field and the anti-chlamydial effects of azelastine are a potential interaction requiring further elucidation.Aim. To explore the underlying anti-chlamydial mechanisms of azelastine.Methodology. We assessed the specificity of azelastine for the chlamydial species and host cell type, the timing of azelastine application and whether the anti-chlamydial effects could be reproduced with different H1R-modulating compounds.Results. We observed similar anti-chlamydial azelastine effects for Chlamydia muridarum as well as for an ocular CT strain in human conjunctival epithelial cells (ocular infection model). Pre-incubating host cells with azelastine before infection mildly reduced chlamydial inclusion numbers and infectivity. Incubation of cells with azelastine initiated concomitantly with the chlamydial infection, or initiated several hours post-infection, reduced inclusion size, number and infectivity, and altered chlamydial morphology. These effects were strongest when azelastine was added shortly after or with the infection. Azelastine effects were not alleviated by increased concentrations of culture medium nutrients. Additionally, we did not observe anti-chlamydial effects when incubating cultures either with a different H1R antagonist or agonist, indicating that azelastine effects are probably H1R-independent.Conclusion. Accordingly, we conclude that azelastine anti-chlamydial effects are not restricted to a specific chlamydial species, strain or culture model, and are probably not mediated by H1R antagonism. Thus, it appears likely that off-target mechanisms of azelastine may explain our observations.

盐酸氮扎elastine抗衣原体作用及组胺H1受体对衣原体发育的影响。
介绍。Azelastine hydrochloride是第二代组胺H1受体(H1R)拮抗剂,在HeLa细胞(生殖器感染模型)中对沙眼衣原体(CT)表现出抗衣原体作用。假设/差距语句。非抗生素药物与CT的相互作用是一个未被充分研究的领域,氮杂elastine的抗衣原体作用是一个潜在的相互作用,需要进一步阐明。探讨氮杂elastine抗衣原体作用机制。我们评估了氮弹性素对衣原体种类和宿主细胞类型的特异性,氮弹性素应用的时机,以及不同的h1 - r调节化合物是否可以复制抗衣原体的作用。我们在人结膜上皮细胞(眼部感染模型)中观察到类似的抗衣原体氮杂弹性蛋白对muridarum衣原体和眼部CT菌株的作用。在感染前用氮弹性蛋白对宿主细胞进行预孵育,可轻度降低衣原体包涵数和感染性。azelastine与衣原体感染同时或在感染后数小时开始孵育细胞,可减少包涵体大小、数量和传染性,并改变衣原体形态。这些效果在感染后不久或与感染同时加入氮唑elastine时最强。氮杂elastine效应不因培养基营养物质浓度的增加而减轻。此外,在不同的H1R拮抗剂或激动剂的培养中,我们没有观察到抗衣原体的作用,这表明azelastine的作用可能与H1R无关。因此,我们得出结论,氮杂elastine抗衣原体的作用并不局限于特定的衣原体物种、菌株或培养模型,并且可能不是由H1R拮抗介导的。因此,azelastine的脱靶机制似乎可以解释我们的观察结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of medical microbiology
Journal of medical microbiology 医学-微生物学
CiteScore
5.50
自引率
3.30%
发文量
143
审稿时长
4.5 months
期刊介绍: Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信